v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating Activities:    
Net loss $ (474,418) $ (684,796)
Adjustments to reconcile net loss to net cash flows used in operating activities:    
Depreciation and amortization 96,477 74,540
Non-cash interest (income) expense, net (378) 931
Stock-based compensation expense 206,593 322,598
Loss from equity method investment 442 2,429
Loss (gain) on remeasurement of warrant liabilities 37,076 (26,996)
Loss (gain) on marketable equity securities and other financial assets 75 (31,808)
Deferred income taxes 1,993 (76,656)
Other expenses, net (3,349) (2,667)
Change in operating assets and liabilities, net of business combinations:    
Receivables reserved for users 50,930 (2,057)
Accounts receivable 19,296 9,765
Prepaid expenses and other current assets 11,257 (47,574)
Deposits and other non-current assets (6,237) (135)
Operating leases, net 1,457 240
Accounts payable and accrued expenses (79,933) (15,659)
Liabilities to users (86,027) (51,195)
Long-term income tax liability (575) (5,266)
Other long-term liabilities 6,108 5,003
Net cash flows used in operating activities (219,213) (529,303)
Investing Activities:    
Purchases of property and equipment (9,649) (14,457)
Cash paid for internally developed software costs (39,287) (29,419)
Acquisition of gaming licenses (1,959) (3,388)
Proceeds from marketable equity securities and other financial assets 24,425 0
Cash paid for acquisition, net of cash acquired 0 (96,507)
Other investing activities, net (482) (3,697)
Net cash flows used in investing activities (26,952) (147,468)
Financing Activities:    
Proceeds from shares issued for warrants 0 44
Purchase of treasury stock (41,184) (17,476)
Proceeds from exercise of stock options 3,336 4,901
Net cash flows used in financing activities (37,848) (12,531)
Net decrease in cash and cash equivalents and restricted cash (284,013) (689,302)
Cash and cash equivalents and restricted cash at the beginning of period 1,778,825 2,629,842
Cash and cash equivalents and restricted cash, end of period 1,494,812 1,940,540
Disclosure of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 1,113,715 1,514,371
Cash reserved for users 381,097 426,169
Total cash, cash equivalents and restricted cash, end of period 1,494,812 1,940,540
Supplemental Disclosure of Noncash Investing and Financing Activities:    
Equity consideration issued for acquisitions 0 460
Investing activities included in changes in accounts payable and accrued expenses 637 9,425
Decrease of warrant liabilities from cashless exercise of warrants 1,470 0
Supplemental Disclosure of Cash Activities:    
Decrease in cash reserved for users 88,556 50,781
Cash paid for interest $ 0 $ 0